BAP Pharma US, a UK-based, award-winning leader in clinical trials supply, will hold the Grand Opening Ceremony of its new US headquarters on Wednesday, April 24, 2024.
 
BAB Pharma’s new US headquarters are in a modern, 28,000 sq. ft. facility in Somerset, NJ. Fully licensed by the New Jersey State Department of Health, some of the capabilities include a 24-hour temperature-controlled and monitored warehouse with ambient (+15°C to +25°C), cold (+2°C to +8°C), and freezer (-20°C) storage facilities.
 
Additionally, BAP Pharma’s US facility can provide in-house label design and print, temperature-controlled clinical secondary packaging, and just-in-time/on-demand labeling.
 
Dr. Parkar, founder and managing director of BAP Pharma, said, “We are excited to have invested in a new modern facility in New Jersey, which will enable further development and growth in our key business area of Comparator Sourcing, as well as now offering Clinical Secondary Packaging & Labelling and Medicines Access services. The facility and location proved a perfect fit for our company. Its proximity to a significant number of global pharmaceutical and biotechnology companies, including our current clients, made it particularly attractive. New Jersey’s excellent transportation network also enhances our ability to deliver products quickly and efficiently throughout the region and around the world.”
 
BAP Pharma opened its headquarters in Landing, NJ in 2016.